Skip to main content
. 2015 Oct;7(10):1756–1764. doi: 10.3978/j.issn.2072-1439.2015.10.26

Table 3. Comparison on the airway and serum inflammatory mediators.

Items of measurement Parameter NAR (n=262) AR (n=377) Control (n=264) P value* P value P value
Airway or serum inflammation Serum total IgE (kU/L) 42.2 (15.8, 120.0) 186.0 (62.0, 356.0) 40.1 (27.5, 44.6) <0.01^ 0.08 <0.01^
Induced sputum Eos (%) 0.5 (0.0, 2.0) 2.0 (0.3, 7.5) 0.25 (0.0, 0.5) <0.01^ 0.08 <0.01^
Induced sputum Neu (%) 50.4 (33.0, 75.3) 45.5 (21.8, 66.5) 47.3 (31.1, 71.8) 0.127 0.352 0.288
FeNO (ppb) 24.1 (14.0, 38.8) 29.1 (18.0, 54.4) 17.0 (12.0, 21.0) <0.01^ <0.01^ <0.01^
Abnormal rates of the airway or serum inflammatory indices Serum total IgE (n, %) 56, 21.4% 211, 56.0% 4, 1.5% <0.01^ <0.01^ <0.01^
Induced sputum Eos (n, %) 43, 16.4% 139, 36.9% 7, 2.7% <0.01^ <0.01^ <0.01^
FeNO (n, %) 127, 48.5% 226, 59.9% 48, 18.2% <0.01^ <0.01^ <0.01^
Positivity of inflammatory indices Total positivity of airway inflammatory indices (n, %) 140, 53.4% 267, 70.8% 64, 24.2% <0.01^ <0.01^ <0.01^

Abnormal rate of serum total IgE: % of IgE ≥150 IU/L; abnormal rate of induced sputum Eos: % of induced sputum Eos ≥2.5%; abnormal rate of FeNO: % of FeNO ≥25 ppb. Data of the airway or serum inflammation were presented as median (interquartile range) because of the non-normal distribution. * denoted the comparison between group NAR and healthy subjects; , denoted comparison between group AR and healthy subjects; , denoted the comparison between group NAR and group AR. Data with ^ indicated the between-group comparison with statistical significance. NAR, non-allergic rhinitis; AR, allergic rhinitis; FeNO, fractional exhaled nitric oxide; ppb, parts per billion.